Back
Bicara Therapeutics Stock Predictions

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
BCAX
Bicara Therapeutics
Last Price:
$13.41
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Bicara Therapeutics Stock Forecast
-
Is Bicara Therapeutics Stock Undervalued?The current Bicara Therapeutics [BCAX] share price is $13.40. The Score for BCAX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
BCAX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Bicara Therapeutics Stock Go Up Next Year?
Data Unavailable
Bicara Therapeutics Stock Rating
Data Unavailable
Bicara Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
52-Week Data
52-Week High:
28.09
52-Week Low:
11.10
Prediction Charts
Market Cap:
617.2M
Price in USD:
13.40
Volume:
333.7K
Beta:
-1.64
Technical Analysis
SMA50:
12.95
SMA100:
16.34
SMA200:
0.00
52-Wk Change:
0%
Stock Predictions
-
Is Bicara Therapeutics stock public?Yes, Bicara Therapeutics is a publicly traded company.
-
What is the Bicara Therapeutics stock quote today?The Bicara Therapeutics stock price is 13.40 USD today.
-
How to buy Bicara Therapeutics stock online?You can buy Bicara Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Mar-7 | 15.58 | 16.55 | 16.68 | 15.53 |
Mar-11 | 15.40 | 14.50 | 15.82 | 14.14 |
Mar-12 | 14.46 | 13.01 | 14.83 | 12.46 |
Mar-13 | 12.90 | 13.35 | 13.42 | 12.04 |
Mar-14 | 13.49 | 12.42 | 14.04 | 12.01 |
Mar-17 | 12.03 | 13.50 | 13.69 | 12.03 |
Mar-18 | 13.35 | 12.44 | 13.47 | 12.33 |
Mar-19 | 12.31 | 12.40 | 12.86 | 11.94 |
Mar-20 | 12.39 | 13.09 | 13.32 | 12.39 |
Mar-21 | 12.93 | 13.24 | 13.44 | 12.68 |
Mar-24 | 13.34 | 13.80 | 13.88 | 12.67 |
Mar-25 | 13.86 | 13.03 | 14.28 | 12.78 |
Mar-26 | 13.04 | 13.10 | 13.24 | 12.56 |
Mar-27 | 13.26 | 13.40 | 13.89 | 12.72 |
Bicara Therapeutics Earnings
Data Unavailable
Bicara Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.07 per share, and a decrease next year of $0.47 per share.
* Bicara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.